AR243182A1 - Procedimiento para la preparacion de la sal sodica cristalina, anhidra, de 5-cloro-3- (tenoil)-2-oxindol-1-carboxiamida - Google Patents
Procedimiento para la preparacion de la sal sodica cristalina, anhidra, de 5-cloro-3- (tenoil)-2-oxindol-1-carboxiamidaInfo
- Publication number
- AR243182A1 AR243182A1 AR88309983A AR30998388A AR243182A1 AR 243182 A1 AR243182 A1 AR 243182A1 AR 88309983 A AR88309983 A AR 88309983A AR 30998388 A AR30998388 A AR 30998388A AR 243182 A1 AR243182 A1 AR 243182A1
- Authority
- AR
- Argentina
- Prior art keywords
- carboxiamida
- anhydra
- oxindol
- tenoyl
- chloro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1987/000201 WO1988005656A1 (en) | 1987-02-02 | 1987-02-02 | Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR243182A1 true AR243182A1 (es) | 1993-07-30 |
Family
ID=22202263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR88309983A AR243182A1 (es) | 1987-02-02 | 1988-02-01 | Procedimiento para la preparacion de la sal sodica cristalina, anhidra, de 5-cloro-3- (tenoil)-2-oxindol-1-carboxiamida |
Country Status (42)
| Country | Link |
|---|---|
| US (1) | US5036099A (es) |
| EP (1) | EP0277738B1 (es) |
| JP (1) | JPS63201184A (es) |
| KR (1) | KR900001422B1 (es) |
| CN (1) | CN1022324C (es) |
| AP (1) | AP52A (es) |
| AR (1) | AR243182A1 (es) |
| AT (1) | ATE73800T1 (es) |
| AU (1) | AU587736B2 (es) |
| BG (1) | BG51042A3 (es) |
| CA (1) | CA1335590C (es) |
| CS (2) | CS265250B2 (es) |
| CY (1) | CY1775A (es) |
| DD (1) | DD267490A5 (es) |
| DE (1) | DE3869149D1 (es) |
| DK (1) | DK44888A (es) |
| EC (1) | ECSP941082A (es) |
| ES (1) | ES2032955T3 (es) |
| FI (1) | FI89598C (es) |
| GR (1) | GR3004200T3 (es) |
| HK (1) | HK132695A (es) |
| IE (1) | IE60000B1 (es) |
| IL (1) | IL85277A (es) |
| IN (1) | IN171799B (es) |
| IS (1) | IS1533B (es) |
| LV (1) | LV10252B (es) |
| MA (1) | MA21171A1 (es) |
| MY (1) | MY102737A (es) |
| NO (1) | NO170581C (es) |
| NZ (1) | NZ223373A (es) |
| OA (1) | OA08710A (es) |
| PH (1) | PH26545A (es) |
| PL (1) | PL149550B1 (es) |
| PT (1) | PT86675B (es) |
| RO (1) | RO105052B1 (es) |
| RU (1) | RU2011381C1 (es) |
| SG (1) | SG27994G (es) |
| SI (1) | SI8810183A8 (es) |
| UA (1) | UA25898A1 (es) |
| WO (1) | WO1988005656A1 (es) |
| YU (1) | YU46766B (es) |
| ZA (1) | ZA88679B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4853409A (en) * | 1988-04-13 | 1989-08-01 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function |
| US4861794A (en) * | 1988-04-13 | 1989-08-29 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis |
| US5118703A (en) * | 1988-10-18 | 1992-06-02 | Pfizer Inc. | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| DE68923673T2 (de) * | 1988-10-18 | 1996-01-18 | Pfizer | Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden. |
| US5059693A (en) * | 1989-10-06 | 1991-10-22 | Pfizer Inc. | Process for making 3-aroyl-2-oxindole-1-carboxamides |
| US5008283A (en) * | 1990-03-19 | 1991-04-16 | Pfizer Inc. | Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| US5006547A (en) * | 1990-03-19 | 1991-04-09 | Pfizer Inc. | Tenidap as an inhibitor of the release of elastase by neutrophils |
| US5122534A (en) * | 1991-02-08 | 1992-06-16 | Pfizer Inc. | Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides |
| DE4111305C2 (de) * | 1991-04-08 | 1994-12-01 | Mack Chem Pharm | Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält |
| WO1997022605A1 (en) * | 1995-12-19 | 1997-06-26 | Pfizer Inc. | Stable, long acting salts of indole derivatives for the treatment of joint diseases |
| EP0826685A1 (en) * | 1996-08-21 | 1998-03-04 | Pfizer Inc. | Stable, long acting salts of carboxamides for the treatment of joint disease |
| DE19854355A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| US7407195B2 (en) | 2004-04-14 | 2008-08-05 | William Berson | Label for receiving indicia having variable spectral emissivity values |
| US7651031B2 (en) * | 2004-10-25 | 2010-01-26 | William Berson | Systems and methods for reading indicium |
| US7619520B2 (en) * | 2005-01-14 | 2009-11-17 | William Berson | Radio frequency identification labels and systems and methods for making the same |
| US7728726B2 (en) * | 2005-01-14 | 2010-06-01 | William Berson | Radio frequency identification labels |
| US7621451B2 (en) * | 2005-01-14 | 2009-11-24 | William Berson | Radio frequency identification labels and systems and methods for making the same |
| US7931413B2 (en) * | 2005-01-14 | 2011-04-26 | William Berson | Printing system ribbon including print transferable circuitry and elements |
| EP3703583A4 (en) | 2017-11-02 | 2020-12-30 | Accurate Medical Therapeutics Ltd. | EMBOLIZATION CATHETER WITH INTEGRATED FILTER |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3767653A (en) * | 1971-06-28 | 1973-10-23 | Squibb & Sons Inc | Thiazines |
| GB1532413A (en) * | 1974-12-23 | 1978-11-15 | Union International Co Ltd | Chenodeoxycholic acid |
| DE2613346C3 (de) * | 1976-03-29 | 1981-07-23 | Diamalt AG, 8000 München | Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung |
| DE3582890D1 (de) * | 1984-02-07 | 1991-06-20 | Pfizer | 2-oxindolzwischenprodukte. |
| CA1250832A (en) * | 1984-03-19 | 1989-03-07 | Pfizer | PREPARATION OF 2-OXINDOLE-1-CARBOXAMIDES; INTERMEDIATE PRODUCTS |
| US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
| US4569942A (en) * | 1984-05-04 | 1986-02-11 | Pfizer Inc. | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents |
-
1987
- 1987-02-02 UA UA4614718A patent/UA25898A1/uk unknown
- 1987-02-02 RO RO140907A patent/RO105052B1/ro unknown
- 1987-02-02 WO PCT/US1987/000201 patent/WO1988005656A1/en active IP Right Grant
- 1987-02-02 US US07/460,137 patent/US5036099A/en not_active Expired - Lifetime
-
1988
- 1988-01-25 ES ES88300561T patent/ES2032955T3/es not_active Expired - Lifetime
- 1988-01-25 AT AT88300561T patent/ATE73800T1/de not_active IP Right Cessation
- 1988-01-25 EP EP88300561A patent/EP0277738B1/en not_active Expired - Lifetime
- 1988-01-25 DE DE8888300561T patent/DE3869149D1/de not_active Expired - Fee Related
- 1988-01-27 IN IN67/DEL/88A patent/IN171799B/en unknown
- 1988-01-28 AP APAP/P/1988/000081A patent/AP52A/en active
- 1988-01-29 DK DK044888A patent/DK44888A/da not_active Application Discontinuation
- 1988-01-29 CA CA000557662A patent/CA1335590C/en not_active Expired - Fee Related
- 1988-02-01 PL PL1988270415A patent/PL149550B1/pl unknown
- 1988-02-01 BG BG82816A patent/BG51042A3/xx unknown
- 1988-02-01 DD DD88312599A patent/DD267490A5/de not_active IP Right Cessation
- 1988-02-01 AR AR88309983A patent/AR243182A1/es active
- 1988-02-01 MA MA21408A patent/MA21171A1/fr unknown
- 1988-02-01 SI SI8810183A patent/SI8810183A8/sl not_active IP Right Cessation
- 1988-02-01 IL IL8527788A patent/IL85277A/en not_active IP Right Cessation
- 1988-02-01 NZ NZ223373A patent/NZ223373A/xx unknown
- 1988-02-01 OA OA59273A patent/OA08710A/xx unknown
- 1988-02-01 ZA ZA88679A patent/ZA88679B/xx unknown
- 1988-02-01 PT PT86675A patent/PT86675B/pt not_active IP Right Cessation
- 1988-02-01 YU YU18388A patent/YU46766B/sh unknown
- 1988-02-01 KR KR1019880000876A patent/KR900001422B1/ko not_active IP Right Cessation
- 1988-02-01 AU AU11160/88A patent/AU587736B2/en not_active Ceased
- 1988-02-01 PH PH36441A patent/PH26545A/en unknown
- 1988-02-02 JP JP63022675A patent/JPS63201184A/ja active Granted
- 1988-02-02 CS CS88648A patent/CS265250B2/cs unknown
- 1988-02-02 CN CN88100555A patent/CN1022324C/zh not_active Expired - Fee Related
- 1988-02-02 IS IS3309A patent/IS1533B/is unknown
- 1988-02-02 MY MYPI88000091A patent/MY102737A/en unknown
- 1988-09-29 NO NO88884329A patent/NO170581C/no not_active IP Right Cessation
-
1989
- 1989-07-18 IE IE26988A patent/IE60000B1/en not_active IP Right Cessation
- 1989-08-01 RU SU894614718A patent/RU2011381C1/ru not_active IP Right Cessation
- 1989-08-01 FI FI893647A patent/FI89598C/fi not_active IP Right Cessation
-
1991
- 1991-11-22 CS CS913541A patent/CS354191A3/cs unknown
-
1992
- 1992-03-31 GR GR920400571T patent/GR3004200T3/el unknown
-
1993
- 1993-11-15 LV LVP-93-1225A patent/LV10252B/xx unknown
-
1994
- 1994-02-22 SG SG27994A patent/SG27994G/en unknown
- 1994-05-05 EC EC1994001082A patent/ECSP941082A/es unknown
-
1995
- 1995-08-24 HK HK132695A patent/HK132695A/xx not_active IP Right Cessation
-
1996
- 1996-04-05 CY CY177596A patent/CY1775A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR243182A1 (es) | Procedimiento para la preparacion de la sal sodica cristalina, anhidra, de 5-cloro-3- (tenoil)-2-oxindol-1-carboxiamida | |
| ES538231A0 (es) | Procedimiento para la preparacion de derivado de esfingosina. | |
| MX7769A (es) | Procedimiento para la preparacion de derivados de pirimidina. | |
| ES538464A0 (es) | Procedimiento para la preparacion de derivados de acilamida. | |
| ES556514A0 (es) | Procedimiento para la preparacion de derivados de 2-oxi-4h-3, 1-benzoxazin-4-ona | |
| ES541705A0 (es) | Procedimiento para la preparacion de derivados de tiazolidina. | |
| ES531814A0 (es) | Procedimiento para la preparacion de nuevos derivados de acidos fenilalcanoicos. | |
| ES552955A0 (es) | Procedimiento para preparar derivados de bencimidazol substituidos | |
| MX159670A (es) | Procedimiento para la preparacion de monohidrato de hidrocloruro de cefalexina cristalino | |
| ES546506A0 (es) | Procedimiento para la preparacion de nuevos derivados de 3-fenil-4-cianopirrol. | |
| AR240460A1 (es) | Procedimeitno para la preparacion de derivados de antraciclina. | |
| ES526880A0 (es) | Procedimiento para la preparacion de sales organicas de n-fosfonometilglicina | |
| ES537010A0 (es) | Procedimiento para preparar derivados de acidos 1-oxido-1, 2-ditiolano-carboxilicos | |
| ES530574A0 (es) | Procedimiento para preparar derivados de pirazol 1,5-a-piridina | |
| MX11650A (es) | Procedimiento para la preparacion de compuestos denaftil-azo-pirazolona | |
| ES530573A0 (es) | Procedimiento para preparar derivados de pirazol-1,5-a-piridina | |
| MX5679E (es) | Procedimiento mejorado para la preparacion del monohidrato de la sal sodica de la mercaptopropionilglina | |
| ES541706A0 (es) | Procedimiento para la preparacion de derivados de tiazolidina. | |
| ES543366A0 (es) | Procedimiento para la preparacion de derivados de feniletilamina. | |
| ES525702A0 (es) | Procedimiento para la preparacion de sales de diarilyodosilo | |
| MX159632A (es) | Procedimiento para la preparacion de derivados de pirimidina 2,4,6,triona | |
| ES536305A0 (es) | Procedimiento para la preparacion de derivados de sulfenamida | |
| ES554828A0 (es) | Procedimiento para preparar derivados de fluoralcanos. | |
| MX12003A (es) | Procedimiento para la preparacion de composicionesherbicidas. | |
| ES542457A0 (es) | Procedimiento para preparar derivados de pirazolpiridina. |